Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02729363 · ClinicalTrials.gov registry record · NA
The Feasibility of the PAINReportIt Guided Relaxation Intervention-Outpatient
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02729363 is a NA study that has completed, run by University of Florida. The registered enrollment target is 30 participants.
The verdict
NCT02729363, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Our goal is to improve the self-management of pain and stress in adult outpatients with sickle cell disease (SCD) by determining the feasibility of a self-managed guided relaxation (GR) stress reduction intervention using a tablet-based mobile device. Currently, opioid analgesics are primarily used to treat SCD pain while self-managed behavioral modalities such as GR, are rarely used. Little is known about the effects or mechanisms of GR on pain and stress, in adults with SCD. Emerging evidence from the hypothalamic pituitary adrenal (HPA) axis theory offer insights for understanding the mechanisms. Adding GR as a supplement to analgesic therapies will address the paucity of self-management strategies for controlling pain in SCD. GR is a simple and cost-effective non-drug intervention that could reduce pain and stress in outpatients with SCD. GR is an intervention where outpatients with SCD are directed to listen to and view audio-visual recordings while they visualize themselves being immersed in that scene.
Interventions
- BEHAVIORAL Guided Relaxation video clip
- BEHAVIORAL Sickle Cell Disease Experience Discussion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02729363
The ClinicalTrials.gov registry entry for NCT02729363 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Guided Relaxation video clip is the first listed.
NCT02729363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02729363 about?
NCT02729363 is a clinical study titled "The Feasibility of the PAINReportIt Guided Relaxation Intervention-Outpatient". Our goal is to improve the self-management of pain and stress in adult outpatients with sickle cell disease (SCD) by determining the feasibility of a self-managed guided relaxation (GR) stress reduction intervention using a tablet-based mobile device. Currently, opioid analgesics are primarily used ...
What is the current status of trial NCT02729363?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-04. Estimated completion is 2017-03-01.
What interventions are being tested in trial NCT02729363?
The interventions under investigation include: Guided Relaxation video clip (BEHAVIORAL), Sickle Cell Disease Experience Discussion (BEHAVIORAL).
Who is sponsoring clinical trial NCT02729363?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.